The effect of different doses of labetalol on bleeding volume during and after dacryocystorhinostomy surgery

Phase 3

Recruiting

• Conditions: Dacryocystorhinostomy.; Dacryoadenitis; H04.0

• Registration Number: IRCT20200825048515N43
• Lead Sponsor: Esfahan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 1 November 2021

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 84

Inclusion Criteria

Candidate for elective dacryocystorhinostomy surgery
Age range 20 to 64 years
Class I and II classification of the American Society of Anesthesiologists

Exclusion Criteria

History of blood diseases, coagulopathy
Allergy to labetalol
Existence of any uncontrolled systemic disease
Recent use of anticoagulants
History of malignant hyperthermia

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Bleeding volume. Timepoint: During surgery and in recovery. Method of measurement: Measure the amount of blood in the suction.

Secondary Outcome Measures

Name	Time	Method
Systolic blood pressure. Timepoint: Immediately before surgery and then every 15 minutes during surgery and then every 15 minutes to an hour in recovery. Method of measurement: Monitoring device.;Diastolic blood pressure. Timepoint: Immediately before surgery and then every 15 minutes during surgery and then every 15 minutes to an hour in recovery. Method of measurement: Monitoring device.;Mean Arterial Pressure. Timepoint: Immediately before surgery and then every 15 minutes during surgery and then every 15 minutes to an hour in recovery. Method of measurement: Monitoring device.;Hear rate. Timepoint: Immediately before surgery and then every 15 minutes during surgery and then every 15 minutes to an hour in recovery. Method of measurement: Monitoring device.